Cart
sales@molnova.com
Brr2 Inhibitor C9
CAS No. 2104030-82-0
Brr2 Inhibitor C9 ( Brr2 Inhibitor 9 )
Catalog No. M22508 CAS No. 2104030-82-0
Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 147 | Get Quote |
|
| 10MG | 260 | Get Quote |
|
| 25MG | 484 | Get Quote |
|
| 50MG | 700 | Get Quote |
|
| 100MG | 981 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBrr2 Inhibitor C9
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
-
DescriptionBrr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
-
SynonymsBrr2 Inhibitor 9
-
PathwayOthers
-
TargetOther Targets
-
Recptorspliceosomal RNA helicase Brr2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2104030-82-0
-
Formula Weight444.5
-
Molecular FormulaC24H20N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1Nc2cc(=O)n(Cc3ccccc3)cc2CN1c1cccc(OCc2cncs2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Meclocycline sulfosa...
Meclocycline (INN) is a tetracycline antibiotic. It is used topically (i.e. for skin infections) as it is totally insoluble in water and may cause liver and kidney damage if given systemically.
-
2-Methoxypyrazine
2-Methoxypyrazine is a natural product.
-
Eprodisate disodium
Eprodisate Disodium is the orally available disodium salt form of Eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.
